Radiation recall dermatitis (RRD) is an inflammatory reaction occurring in a previously irradiated area, precipitated by the administration of certain drugs. The drugs most commonly associated with RRD are intravenous antineoplastic agents. The frequency of development of this toxicity in clinical practice is unclear. We report a case of RRD induced by ixabepilone, an epothilone antineoplastic agent, with successful rechallenge utilizing an alternative dosing regimen.
CamidgeRPriceA. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol2001; 59(3): 237–245.
2.
SusserWSWhitaker-WorthDLGrant-Kels. Mucocutaneous reactions to chemotherapy. Am Acad Dermatol1999; 40(3): 367–367.
3.
Kossoff EB, Ngamphaiboon N, Laudico TJ and O’Connor TL. Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients. Med Oncol 2010; 28(Suppl 1); 115–120.
4.
SmithJWVukelaSJRabeAC. Preliminary toxicity results of a phase II randomized trial of weekly or every 3-week ixabepilone in metastatic breast cancer. San Antonio breast cancer symposium, San Antonio, TX, USA. 13 December 2009 (abstr 6099).
5.
MichaudLB. The epothilones: how pharmacology relates to clinical utility. Ann Pharmacother2009; 43(7): 1294–1309.
6.
PhillipsKAUrchMBishopJF. Radiation-recall dermatitis in a patient treated with paclitaxel. J Clin Oncol1995; 13: 305–305.
7.
RaghavanVTBloomerWDMerkelDE. Taxol and radiation recall dermatitis. Lancet1993; 41: 1354–1354.
8.
ShenkierTGelmonK. Paclitaxel and radiation-recall dermatitis. J Clin Oncol1994; 412: 439–439.
9.
MizumotoMHaradaHAsakuraH. Frequency and characteristics of docetaxel-induced radiation recall phenomenon. Int J Radiat Oncol Biol Phys2006; 66: 1187–1191.
